Eta Variant (B.1.525) Peptide Pool SARS-CoV-2 (Spike Glycoprotein)

This peptide pool with 31 peptides covers all mutations in the Spike Glycoprotein derived from the eta variant B.1.525 of SARS-CoV-2 which emerged in Angola in December 2020..

Possilbe applications: T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response.

Each peptide is purified by solid phase extraction and checked on its purity by ESI-MS.
This peptide pool is supplied lyophilized as trifluoroacetate salt.

Peptide sequences included (15 nmol (approx. 25ug)/peptide for stimulation of 2,5 x 108 cells):
KVFRSSVLHSTRDLF PFLGVHKNNKSWMES PIGAGICASYQTHTN SSVLHSTRDLFLPFF VHKNNKSWMESEFRV GICASYQTHTNSPRR HSTRDLFLPFFSNVT NKSWMESEFRVYSSA SYQTHTNSPRRARSV DLFLPFFSNVTWFHV
MESEFRVYSSANNCT HTNSPRRARSVASQS PFFSNVTWFHVISGT FRVYSSANNCTFEYV LLAGTITSGWTLGAG NVTWFHVISGTNGTK YQAGSTPCNGVKGFN TITSGWTLGAGAALQ FHVISGTNGTKRFDN STPCNGVKGFNCYFP
GWTLGAGAALQIPFA SGTNGTKRFDNPVLP NGVKGFNCYFPLQSY GTKRFDNPVLPFNDG GTNTSNQVAVLYQGV VIKVCEFQFCNDPFL SNQVAVLYQGVNCTE CEFQFCNDPFLGVHK AVLYQGVNCTEVPVA FCNDPFLGVHKNNKS
QGVNCTEVPVAIHAD

Dissolve in a minimum amount of pure DMSO (approx. 40µL) and dilute with water to the desired concentration. Please pay attention that the final concentration of DMSO must be below 1% (v/v) to avoid toxicity in the biological system.

Protein ID: P0DTC2 (swiss prot)